+
Increase
-
Decrease
=
Normal
Default mode
High Contrast
High Contrast
Aa
Home
About us
Introduction
Staff
Population and area
Statement
News
Mesotelioma Registry
Governance
Methods
Statement
Activities
Staff
Publications
Data
Veneto Data
Tumour site data
ULSS Data
Publications
Research publications
Meetings
Oral presentations
Posters
Links
Contacts
Enter Part of Title
Display #
5
10
15
20
25
30
50
100
All
Cancer cost profiles: The Epicost estimation approach
Cost items in melanoma patients by clinical characteristics and time from diagnosis
Cost-effectiveness of a melanoma screening programme using whole disease modelling
Cutaneous melanoma in adolescents and young adults
Differences in direct costs of patients with stage I cutaneous melanoma: A real-world data analysis
Direct Costs of Care for Adults with Soft Tissue Sarcomas: A Population-Based Study
Health care costs of cancer patients at the end of life: estimates from the EPICOST-2 study
Health Outcomes and Direct Healthcare Costs in Patients with Melanoma: Associations with Level of Education
Malignant Melanoma: Direct Costs by Clinical and Pathological Profile
Non-Small-Cell Lung Cancer: Real-World Cost Consequence Analysis
Patterns of Care and Cost Profiles of Women With Breast Cancer in Italy: EPICOST Study Based on Real World Data
Quality management of cutaneous melanoma: impact on short-term outcomes and costs
Real-world data for direct stage-specific costs of melanoma healthcare
Renal cell carcinoma: the population, real world, and cost-of-illness
Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs
The Economic Impact of Rectal Cancer in Italy: results from the Epicost study
The Economic Impact of Rectal Cancer in Italy: results from the Epicost study
The Economic Impact of Rectal Cancer: A Population-Based Study in Italy
The Economic Impact of Rectal Cancer: A Population-Based Study in Italy List of Authors
Use of an Artificial Neural Network to Identify Patient Clusters in a Large Cohort of Patients with Melanoma by Simultaneous Analysis of Costs and Clinical Characteristics